Please login to the form below

Not currently logged in
Email:
Password:

Piramal

This page shows the latest Piramal news and features for those working in and with pharma, biotech and healthcare.

India denies Vertex patent on cystic fibrosis drug Orkambi

India denies Vertex patent on cystic fibrosis drug Orkambi

The patent was opposed by the Indian Pharmaceutical Alliance (IPA), a trade organisation representing India's larger pharmaceutical companies, including Cipla, Dr Reddy's Labs, Lupin, Nicholas Piramal, Ranbaxy and Wockhardt.

Latest news

  • EMA unveils draft guidelines for Alzheimer’s disease research EMA unveils draft guidelines for Alzheimer’s disease research

    Although the last few years have seen a number of Alzeimer's diagnostics approved, among them GE Healthcare Vizamyl (flutemetamol) and Piramal's Neuraceq (florbetaben F18), research progress for a treatment

  • Piramal sells clinical research arm to Indoco Piramal sells clinical research arm to Indoco

    Piramal sells clinical research arm to Indoco. Piramal Clinical Research sold for an undisclosed sum. ... Dr Swati Piramal, vice chairman of Piramal Enterprises, told PMLiVE: “ The clinical trial facility was for bioequivalence studies mainly for

  • Takeda pipeline hit by fasiglifam failure Takeda pipeline hit by fasiglifam failure

    Lilly has LY2881835 in early clinical trials, while Piramal recently started trials of its P11187 candidate and Connexios Life Sciences has also brought CNX 011-67 into the clinic.

  • CHMP backs Piramal's Alzheimer's imaging agent CHMP backs Piramal's Alzheimer's imaging agent

    CHMP backs Piramal's Alzheimer's imaging agent. Neuraceq recommended for approval in Europe. ... Piramal acquired rights to Neuraceq from Bayer in 2012, saying at the time it expected the global market for PET imaging agents for AD to reach $1.5bn at peak

  • Piramal pays $635m for US data firm

    Piramal pays $635m for US data firm. Decision Resources Group purchase reflects increasing demand for drug market information. ... Piramal Healthcare, the India-based pharma commpany, is to acquire US healthcare research firm Decision Resources Group for

More from news
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2016 Deal Watch October 2016

    So when Janssen announced this month it had divested five injectable pain products to Piramal for $175m, it is assumed this was a consequence of low margins and manufacturing issues. ... 200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5

  • The pill branding The pill branding

    TV ads show desperate young women and crying girls. The slogan of the Indian manufacturer Piramal for the drug i-pill is: “ Because prevention is better than abortion”.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Piramal | Healthcare

    Piramal | Healthcare. Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. ... Piramal | Healthcare.

  • Manufacturing, packaging and logistics

    Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics